rs1536898
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001351661.2(MACROD2):c.418+190612T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.908 in 152,144 control chromosomes in the GnomAD database, including 62,861 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.91   (  62861   hom.,  cov: 30) 
Consequence
 MACROD2
NM_001351661.2 intron
NM_001351661.2 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.71  
Publications
1 publications found 
Genes affected
 MACROD2  (HGNC:16126):  (mono-ADP ribosylhydrolase 2) The protein encoded by this gene is a deacetylase involved in removing ADP-ribose from mono-ADP-ribosylated proteins. The encoded protein has been shown to translocate from the nucleus to the cytoplasm upon DNA damage. [provided by RefSeq, May 2017] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.974  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MACROD2 | NM_001351661.2 | c.418+190612T>A | intron_variant | Intron 5 of 17 | ENST00000684519.1 | NP_001338590.1 | ||
| MACROD2 | NM_001351663.2 | c.418+190612T>A | intron_variant | Intron 5 of 17 | NP_001338592.1 | |||
| MACROD2 | NM_080676.6 | c.418+190612T>A | intron_variant | Intron 5 of 16 | NP_542407.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.908  AC: 137977AN: 152026Hom.:  62798  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
137977
AN: 
152026
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.908  AC: 138099AN: 152144Hom.:  62861  Cov.: 30 AF XY:  0.908  AC XY: 67508AN XY: 74372 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
138099
AN: 
152144
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
67508
AN XY: 
74372
show subpopulations 
African (AFR) 
 AF: 
AC: 
40572
AN: 
41520
American (AMR) 
 AF: 
AC: 
13893
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2883
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
5141
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
4374
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
9230
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
271
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
59043
AN: 
68000
Other (OTH) 
 AF: 
AC: 
1887
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 641 
 1281 
 1922 
 2562 
 3203 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 904 
 1808 
 2712 
 3616 
 4520 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
3309
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.